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Abstract 
 
Several studies have shown that genes related to cardiac muscle and function 
thrive in low glucose concentrations, whereas cells over actively replicate and do not 
reach full maturation in high glucose concentrations. Data suggests that blocking the 
pentose phosphate pathway induces cardiac maturation. The pentose phosphate pathway 
is responsible for generating ribose sugars that contribute to making nucleotides and 
NADP+/NADPH. Prolonged activation of the pentose phosphate pathway leads to excess 
nucleotide synthesis resulting in immature cardiomyocytes leading to congenital heart 
defects. This paper discussed how the pentose phosphate pathway is involved in the 
inhibition of fetal cardiomyocytes in high glucose conditions. 
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Glucose in Healthy Pregnancy  
In a healthy pregnancy, blood glucose levels remain stable in utero. A healthy 
pregnancy means that the blood glucose levels are normal. Hyperglycemia increases the 
likelihood by 2-5 fold in the developing congenital heart defects independent of genetic 
factors (Nakano, 2017). Maternal blood glucose levels reflect the blood glucose levels of 
the fetus. In the US, roughly 4000 children are born every year with a congenital heart 
defect, CHD (Mccommis et al, 2013). Some of the most common CHD include 
ventricular septal defect and tetralogy of Fallot.  
Embryonic stem cell cardiac differentiation has shown that cells switch from 
glycolysis to oxidation phosphorylation during the latter stages of gestation (Rao, 2013). 
The switch to oxidative metabolism is due to the more efficient production of ATP. The 
maturing heart has a higher energy demand. Compromising this switch causes 
deficiencies in sarcomere formation and contractile force.  
In a healthy fetus, transcript levels of aldolase and transketolase are reduced 
(Chung et al, 2010). Aldolase and transketolase are enzymes in the reductive phase of the 
pentose phosphate pathway. They help to shunt glucose away from glycolysis.  The 
transcript levels of aldolase and transketolase would suggest that during cardiogenesis, 
there is an uncoupling of glycolysis from the pentose phosphate pathway. There is also an 
increase in oxygen consumption in healthy fetus hearts.  
Glucose Metabolism and Maturation of Cardiomyocytes  
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To determine the role of glucose metabolism in the maturation of human 
embryonic stem cells cardiomyocytes, hESC-CMs researchers performed six methods 
with cells cultured in various concentrations of glucose (Nakano, 2017). The hESC-CMs 
originate from inner cell mass of blastocysts from donated fertilized eggs.  
The first method included hESC-CMs stained with JC-1, a green fluorescent dye 
that turns red upon detection of active mitochondria. In low glucose media, a higher level 
of JC-1 was significantly more present meaning, a higher abundance of active 
mitochondria detected. In the second method, intracellular lactate levels of hESC-CMs 
were measured using a lactate nanosensor, Laconic. With both lactate and differentiated 
hESC-CMs in standard 25 mM glucose plate, there is an increase in intracellular lactate 
levels. Along with the addition of pyruvate and sodium cyanide (NaCN), an inhibitor of 
mitochondrial respiration, a minimal increase can be seen. The minimum increase would 
suggest that glucose does not actively metabolize pyruvate alone. However, when 
pyruvate and NaCN are added to hESC-CMs in low glucose media, there was a 
significant increase in intracellular lactate levels. In the third method, cellular respiration 
of the hESC-CMs was studied using XF24 Extracellular Flux Analyzer. This tool 
measures the oxygen consumption rate, ATP linked respiration and maximum respiration 
capacity presented higher in low glucose conditions. The fourth method measured hESC-
CMs calcium kinetics using Ca2+ transient assay. The maximum upstroke (Vmax) were 
significantly faster in low glucose media. The Vmax of calcium kinetics measurements 
suggests that high glucose concentrations have some role in inhibiting the maturation of 
hESC-CMs. The fifth method, assessed electrophysiological properties of the hESC-CMs 
using a multi-electrode array culture plate. This tool was used to measure maximum 
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upstroke velocity (dV/dtmax) of field potential. In glucose-restricted media, there was a 
significant increase in maximum upstroke velocity. The sixth concluding method 
examined cell contractility using digital imaging with the MotionGUI program. The 
average contraction and relaxation speed were higher in hESC-CMs in 0 mM glucose 
media.   
Nakano et al (2017) research suggests that mitochondria can metabolize pyruvate 
in low glucose conditions as opposed to glucose enriched environments. The methods 
used by the researchers show that hESC-CMs can reach functional maturation in low 
glucose conditions.  
Pentose Phosphate Pathway 
A review of Stincone et al (2015) discussed the discovery, biochemistry and 
regulation of the pentose phosphate pathway (PPP) in the context of deficiencies causing 
metabolic disease and the role of the pathway in neurons, stem cell potency and cancer 
metabolism. PPP, also known as the pentose shunt and the hexose monophosphate shunt, 
provides precursors for nucleotide biosynthesis and reducing molecules for anabolism 
and protecting against oxidative stress.  
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The pathway occurs in the cytosol of the cell. It is an alternate route for glucose 
oxidation without direct consumption of ATP. Glucose-6-phosphate can either continue 
through glycolysis or be shunted off to the 
pentose phosphate pathway. The glucose-6-
phosphate path is directed depending on the 
current needs of the cell and the 
concentration of NADP+ in the cytosol. The 
oxidative phase of the pathway generates 
ribulose while the reductive phase generates 
NADPH.  
PPP is an important modulator of the 
overall redox state of the cell through 
reduction of NADP+ to NADPH, a cofactor     
for several key cellular enzymes (Larsen and 
Gutterman, 2006). NADP+ maintains reducing equivalents that are important to 
counteract oxidative damage and specific 
reductive synthesis reactions. Oxidative 
damage includes free radicals flowing inside 
of a cell that can lead to apoptosis. The 
conversion of ribonucleotides to 
deoxyribonucleotides requires NADPH as the 
electron source. This conversion implies that any cell that is rapidly multiplying needs a 
lot of NADPH. 
Figure 1: Pictured above is the 
Pentose Phosphate Pathway. 
Opperoes F. Kinetoplastid 
Metabolism. 5.6. Pentose-
phosphate pathway. 2016 
[accessed 2019 Apr 30]. 
http://big.icp.ucl.ac.be/~opperd/
metabolism/Kinetoplastida/Blog/
Entries/2016/1/31_5.6._Pentose-
phosphate_pathway.html 
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Role of Pentose Phosphate Pathway in Congenital Heart Defects  
Ventricular septal defect (VSD) is a common CHD. The wall or septum 
separating the left and right ventricles is missing in the VSD. This in turn interrupts the 
flow of oxygen rich blood. The oxygen rich blood then flows back into the lungs. 
Adverse effects include heart failure and pulmonary hypertension due to the excessive 
workload of the heart. Small 
ventricular septal defects may close on 
their own while larger ones may 
require surgery (Mayo Clinic Staff, 
2018). Ventricular septal defect can be 
seen in Figure 2 along with an image 
of a normal heart.  
Another common congenital heart defect is  tetralogy of Fallot. As the name 
suggests, this includes four birth defects: pulmonary valve stenosis, VSD, overriding 
aorta and right ventricular hypertrophy. Unlike, VSD tetralogy of Fallot involves the 
interruption of oxygen poor blood flow. This defect causes oxygen poor blood to 
circulate throughout the body. As a result, infants may present with cyanosis due to lack 
of oxygen. Pulmonary valve stenosis reduces blood flow to the lungs due to the 
constriction of the pulmonary valve. 
VSD was mentioned in the preceding 
paragraph. The overriding aorta 
combines oxygen rich blood and oxygen 
poor blood from the right ventricle and 
Figure 2: Depicts a normal heart and a 
heart with a ventricular septal defect. 
Mayo Clinic Staff. Ventricular septal 
defect (VSD). Mayo Clinic. 2018 Mar 9 
[accessed 2019 Apr 30]. 
https://www.mayoclinic.org/diseases-
conditions/ventricular-septal-
defect/symptoms-causes/syc-20353495 
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left ventricle, respectively. The combining of the blood is due to the shifted position of 
the aorta in tetralogy of Fallot. Right ventricular hypertrophy is the thickening of the right 
ventricle wall. The heart stiffens and in untreated conditions, fails. Tetralogy of Fallot 
requires surgery and continued medical care throughout life (Mayo Clinic Staff, 2018).  
 
Larsen and Gutterman (2006) 
conducted a study to relate hypoxia, 
coronary dilation and the pentose phosphate 
pathway. Since Gupte and Wolin (2005) 
have reported that hypoxia promotes 
relaxation in the absence of the 
endothelium. The current researchers used 
endothelium-denuded bovine coronary 
artery (BCA) to demonstrate that hypoxia 
promotes the oxidation of NADPH. Hypoxic 
vasorelaxation of arteries is a mechanism in 
which oxygenation in cardiac tissue is 
maintained. Vasorelaxation is enhanced in glucose free conditions with the addition of 
pyruvate, showing consistency with sensitivity to the PPP. The researchers explained that 
inhibition of the PPP reduces reactive oxygen species (ROS) generation in the BCA, and 
that ROS can inhibit potassium channels and other proteins involved in vasodilation. It is 
important to note that too much flow through the PPP is not conductive up an efficient 
energy supply for the fetal heart but too little flow through the PPP can be equally 
Figure 3: Tetralogy of Fallot. Mayo 
Clinic Staff. Tetralogy of Fallot. 
Mayo Clinic. 2018 Mar 9 [accessed 
2019 Apr 30]. 
https://www.mayoclinic.org/disease
s-conditions/tetralogy-of-
fallot/symptoms-causes/syc-
20353477 
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harmful as the PPP is needed for the production of nucleotides and protection against 
oxidative stress of the cell.   
Several studies have demonstrated the effects of the PPP on the cardiac 
differentiation of stem cells.  
Chung et al (2007) conducted a study to establish a relationship between 
mitochondrial oxidative metabolism and the differentiation of cardiomyocytes. Using 
embryonic stem cells, researchers were able to show that mitochondrial oxidative 
metabolism is required for the differentiation and specification of cardiomyocytes. The 
mitochondrial oxidation perform a sufficient amount of ATP to supply the increasing 
energy demands of the constant contracting heart. The study showed that glycolytic 
metabolism was not efficient enough but that mitochondrial oxidation metabolism must 
take place to convert the stem cells into a functional cardiac phenotype.  
Mccommis et al (2013) designed a study to determine how overexpression of 
hexokinase 2 leads to hypertrophy by increasing the flux through the PPP. The 
researchers used neonatal rat ventricular myocytes infected with a hexokinase 2 
adenovirus and treated them with phenylephrine. The study found that overexpression of 
hexokinase 2 decreased hypertrophy in neonatal rat ventricular myocytes. Hexokinase 2 
increases the activity of glucose-6-phosphate dehydrogenase within the PPP. The 
increased flux through the PPP reduces ROS accumulation.  
Nakano et al (2017) studied cardiac maturation through glucose metabolism. The 
researchers used stem cells in varying concentrations of glucose to better understand how 
cardiac maturation is inhibited in high levels of glucose. They found that the pentose 
phosphate pathway was responsible for the increased number of immature 
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cardiomyocytes in high glucose media. It is important to note that glucose comes from 
the maternal source. Thus the glucose deprivation experienced in the latter stages may be 
from isoform switching (Nakano, 2017). They connected this as a possible underlying 
mechanism for the development of CHD.  
Helle et al (2017) studied how first trimester plasma glucose levels may be an 
indicator for the risk of the development of CHD in children of mothers with and without 
diabetes. In a case-control study, researchers measured random samples of plasma 
glucose levels in expectant mothers. The researchers found that higher plasma glucose 
levels corresponded with an increased risk for CHD. It was also reported that children of 
diabetic mothers with controlled glucose levels still had an increased risk of developing 
CHD. This would suggest that the variation in plasma glucose levels may be the 
underlying mechanism for the increased likelihood of the development of CHD. 
Variation in plasma glucose levels are higher in mothers with diabetes (Helle et al 2018). 
The researchers concluded that measuring random plasma glucose levels during the first 
trimester could be a better indicator for the likelihood of developing CHD.  
Malandraki-Miller et al (2018) studied the oxidative environment of the 
cardiomyocytes and how this impacts the cell’s ability to become differentiated. Using 
cardiac progenitor cells, researchers observed changes made in development in an 
oxidative state. Transplanted stem cells in vivo can display one or a combination of three 
characteristics: (1) replicate themselves and/or differentiate into mature cardiomyocytes, 
(2) regenerate cardiomyocytes, (3) through paracrine mechanisms apply benefits to the 
cell, (Malandraki- Miller, 2018). They found that oxidative metabolism contributed to the 
differentiation of progenitor cells to mature cardiomyocytes.  
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An increased glucose utilization and decreased fatty acid metabolism is 
accompanied by cardiac hypertrophy (Mccommis et al, 2013). Flux through the PPP 
increases during this time. Glucose metabolism is initiated by uptake by glucose 
transporters and glucose phosphorylation by a hexokinase leading to the formation of 
glucose-6-phosphate. A particular hexokinase, named hexokinase 2 is regulated by 
insulin and hypoxia. This enzyme was studied in neonatal rat ventricular myocytes. An 
overexpression of hexokinase 2 decreased hypertrophy in the neonate rats (Mccommis et 
al, 2013). Hexokinase 2 works to increase the flux through the PPP by increasing G6PDH 
activity. A result of hypertrophy, ROS accumulation is reduced with the increase G6PDH 
activity. Glucose shuttling to the PPP may be used to reduce CHD in neonatal rats with 
the overexpression of hexokinase 2. 
Mass spectrometry showed that glucose deprivation led to a significant decline in 
levels of metabolites in purine metabolism, pyrimidine metabolism, the pentose 
phosphate pathway, the hexosamine pathway and glycolysis (Nakano, 2017). Each 
pathway was inhibited to determine which route was inhibiting cardiac maturation in the 
fetus. The results show that when 6AN (6-[cyclohexa-2, 5-dien-1-ylideneamino] 
naphthalene-2-sulfonate) and DHEA (didehydroepiandrosterone), inhibitors of G6PD, 
were added cardiomyocytes matured (Nakano, 2017). This maturation showed that the 
pentose phosphate pathway was involved in inhibiting cardiomyocyte maturation.   
To test if cardiac maturation is inhibited by NADPH or the pentose sugars 
produced that aid in nucleotide synthesis, excess thymidine was added to hESC-CMs 
(Nakano, 2017). Excess thymidine blocks nucleotide synthesis by forming deoxycytidine. 
The excess thymidine blocks resulted in an increase in TNNT2 and NKX2-5 expression 
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(Nakano, 2017). TNNT2 is a gene that codes for cardiac troponin T. NKX2-5 codes for a 
homeobox-containing transcription factor that is important in heart formation and 
development. This increase would suggest that nucleotide metabolism regulates 
maturation as opposed to the concentration of NADPH.  
The formation of the heart is regulated by non-genetic factors more intensely 
during late stage of cardiogenesis in the womb (Helle et al 2017). The placenta and fetal 
liver work together to meet the fetal metabolism needs. During continued levels of high 
maternal blood glucose levels, the fetus can develop an obesity- induced insulin 
resistance leading to a defective oxidative phosphorylation (Rao, 2013). The defective 
oxidative phosphorylation takes rise due to increased flux through the PPP. Increased 
flux through the PPP inhibits the abundance of mature mitochondria. This factor does not 
allow the cardiomyocytes to sustain themselves and the cardiovascular system as a 
whole. Essentially, differentiation and maturation of cardiomyocytes is parallel with 
increased oxidative metabolism.  
Further Studies/ Conclusion  
With the advances of the understanding of glucose metabolism through the 
pentose phosphate pathway, the numbers of those affected by CHD can decrease 
drastically. This understanding will allow scientists to understand the proliferating 
cardiomyocytes better and possibly induce maturation. These studies could also be useful 
in studying cancerous cells and treatment.  
Glucose metabolism through the pentose phosphate pathway causes the rapid 
proliferation of fetal cardiomyocytes. This rapid proliferation leads to many immature 
cells contributing to the development of congenital heart defects. Through extensive 
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testing, conclusions can be made that when G6PD is inhibited, the cardiomyocytes 
mature more specifically with the blocking of nucleotide synthesis through the pentose 
phosphate pathway. The pentose phosphate pathway serves as an oxygen sensor in 
vascular muscle that regulates hypoxic coronary vasodilation. From these results, an 
underlying mechanism for the high rates of CHD may be determined. Another treatment 
that could be further tested is stem cell therapy. Stem cell therapy is a great option 
because it promotes repair of injured tissue by generating new healthy cells. This could 
replace the need and wait of heart transplants. However, there are some cons with this 
approach including ethical concerns and the possibly of triggering an immune response if 
the body recognizes the stem cells as foreign. This approach is already being used in 
other medical endeavors and proving to be an alternative to transplants.  
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